HARRISBURG, Pa. (WHTM) — The Pennsylvania Department of Drug and Alcohol Programs joined the Department of Health, Pennsylvania Commission on Crime and Delinquency (PCCD and South Central EMS) to discuss the importance of carrying drug naloxone and highlight how the public, businesses, and first responders can access the drug.
“As we work to deal with the increase in overdose deaths across the commonwealth, expanding access to naloxone continues to be a top priority of the Wolf Administration,” DDAP Secretary Jen Smith said. “You never know when you may come across an individual suffering from an overdose. There are numerous ways that Pennsylvanians can access life-saving naloxone and we’re here today to encourage that people take advantage of those resources.”Polarizing bill to eliminate permits for concealed carry moves in House.
South Central EMS is designated as the Centretlaized Coordinating Entity (CCE) for Dauphin County through the National for The First Responders Program. The entities are the primary source of contact for first responders and receive naloxone at no cost. These CCE’s distribute naloxone to the following first responder groups:
- Organizations that provide services and supports to individuals who are currently using substances, such as harm reduction organizations;
- Individuals with substance use disorder (SUD) and/or opioid use disorder (OUD)
- Individuals leaving a SUD/OUD treatment facility and/or in recovery
- Individuals receiving care in emergency departments for an overdose
- Probation and Parole Officers
- Law enforcement agencies (including municipal police, sheriff’s offices, campus police, campus security, school resource officers, and park rangers)
- Firefighters (both volunteer and paid firefighters)
- Emergency medical services, advanced life support, basic life support, and emergency medical technicians
- Other first responder organizations serving individuals and communities impacted by substance use that are legally organized and trained to respond to overdose emergencies and administer intranasal naloxone.
To learn more about the Department of Drug and Alcohol Programs, click here.